Sandoz (SIX:SDZ / OTCQX:SDZNY), the global leader in affordable medicines, will host its 2026 capital markets day for investors and analysts on Tuesday, 8 September, from 13:30 to 17:00 UK time at the London Stock Exchange. The event will be available both in-person by invitation only and via a live webcast. Details of how to access the live webcast are available here.
The formal part of the event, webcast live, will begin at 13:30. In-person attendance will be by invitation only on a first-come, first-served basis; invitations will be distributed in due course. In addition, Sandoz plans to host an investor and analyst site visit in Slovenia from 9-10 November, providing further insight into the Company’s new biosimilars development and supply-chain hub. Attendance will also be by invitation only and the event will not be webcasted.
Sandoz, which celebrated 20 years of pioneering biosimilars in 2026, is positioning itself to maximize value in what it calls the "golden decade for biosimilars." With a portfolio of approximately 1,300 medicines and net sales of USD 11.1 billion in 2025, the company aims to leverage its leadership in affordable medicines to drive growth. The capital markets day is expected to outline strategic initiatives and financial targets, underscoring the importance of biosimilars in expanding patient access and generating healthcare savings.
The site visit in Slovenia will showcase Sandoz’s new biosimilars development and supply-chain hub, which is central to its strategy. This hub is designed to enhance the company's capabilities in research, development, and manufacturing of biosimilars, which are critical for addressing diseases from common illnesses to cancer. The event provides a unique opportunity for investors to gain firsthand insight into the company's operations and future plans.
Sandoz, headquartered in Basel, Switzerland, traces its heritage back to 1886 and employs over 20,000 colleagues of 100 nationalities. The company's purpose is pioneering access for patients, and it reaches over one billion patients globally. The capital markets day and site visit are key components of Sandoz's communication strategy to engage with the financial community and highlight its growth prospects in the biosimilars market.
